CLASS II ONGOING Device recall · Reported 15 Mar 2023 · FDA Enforcement Report

Heartsine Samaritan PAD: SAM 350P semi-automatic recalled

HeartSine Technologies is recalling Heartsine Samaritan PAD: SAM 350P semi-automatic defibrillator, SAM 360P fully automatic, distributed in 8 states. The recall was initiated on 1 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF/UDI-DI/Serial Numbers: SAM 350P/05060167120671/17D00006810, 19D00027547, 19D00030364, 20D00000454, 20D00000868, 20D00006232, 22D91125401, 16D01000729, 22D91145062; SAM 360P/5060167127120, 5060167128028/20E90006314, 21E91040881; SAM 500P/5060167126505, 5060167125843/17B00003113, 20B90000080
Quantity recalled13

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1217-2023
FDA event ID
91659
Recalling firm
HeartSine Technologies, Belfast
Classification
Class II
Status
Ongoing
Recall initiated
1 Feb 2023
FDA classified
3 Mar 2023
Reported
15 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

1 Feb 2023Recall initiated by company
3 Mar 2023Classified by FDA+30 days
15 Mar 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Automated external defibrillators were potentially distributed with the incorrect language configuration, which can lead to a delay in therapy or no therapy.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

Heartsine Samaritan PAD: SAM 350P semi-automatic defibrillator, SAM 360P fully automatic defibrillator, SAM 500P semi-automatic defibrillator with CPR Advisor

Where it was distributed

US: NJ, PA, WI, NE, TX, PA, CA, AZ, AR OUS: Australia, Czechia, Canada, New Zealand

ArkansasArizonaCaliforniaNebraskaNew JerseyPennsylvaniaTexasWisconsin

Questions about this recall

Is Heartsine Samaritan PAD: SAM 350P semi-automatic defibrillator, SAM 360P fully automatic recalled?

Yes. HeartSine Technologies recalled Heartsine Samaritan PAD: SAM 350P semi-automatic defibrillator, SAM 360P fully automatic on 1 Feb 2023. The recall is Class II and its status is Ongoing. Recall number Z-1217-2023.

Why was it recalled?

Automated external defibrillators were potentially distributed with the incorrect language configuration, which can lead to a delay in therapy or no therapy.

Which lots are affected?

REF/UDI-DI/Serial Numbers: SAM 350P/05060167120671/17D00006810, 19D00027547, 19D00030364, 20D00000454, 20D00000868, 20D00006232, 22D91125401, 16D01000729, 22D91145062; SAM 360P/5060167127120, 5060167128028/20E90006314, 21E91040881; SAM 500P/5060167126505, 5060167125843/17B00003113, 20B90000080

Where was it sold?

US: NJ, PA, WI, NE, TX, PA, CA, AZ, AR OUS: Australia, Czechia, Canada, New Zealand

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from HeartSine Technologies

All 7

Other Pacemakers & Defibrillators recalls

All 494